Accendra Health
217 hedge funds and large institutions have $1.41B invested in Accendra Health in 2022 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 83 increasing their positions, 58 reducing their positions, and 49 closing their positions.
290% more call options, than puts
Call options by funds: $6.39M | Put options by funds: $1.64M
43% more repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 58
4% less funds holding
Funds holding: 225 → 217 (-8)
5.88% less ownership
Funds ownership: 100.81% → 94.93% (-5.9%)
10% less first-time investments, than exits
New positions opened: 44 | Existing positions closed: 49
24% less capital invested
Capital invested by funds: $1.85B → $1.41B (-$438M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$23M |
| 2 |
Janus Henderson Group
London,
|
+$20.4M |
| 3 |
Nuveen
Charlotte,
North Carolina
|
+$13.3M |
| 4 |
BlackRock
New York
|
+$9.91M |
| 5 |
Millennium Management
New York
|
+$7.34M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$28.6M |
| 2 |
AIM
Artemis Investment Management
Edinburgh,
United Kingdom
|
-$27.2M |
| 3 |
Boston Partners
Boston,
Massachusetts
|
-$14M |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$12.1M |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$11.9M |
ACH Hedge Fund Activity: Q4 2022 in Review
217 of the 6,240 institutional investors tracked by Wall St. Rank reported a position in Accendra Health (ACH) for Q4 2022, worth a combined $1.41B — down 24% from $1.85B a quarter earlier.
Sellers outnumbered buyers: 49 funds closed out of ACH and 44 opened new positions — a net loss of 5 holders — while 58 trimmed existing stakes and 83 added.
The largest buyer was Deerfield Management, opening a new position worth an estimated $23M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $28.6M sold.
- 217 institutional investors held Accendra Health (ACH) as of Q4 2022, down from 225 in Q3 2022.
- Funds reported $1.41B of Accendra Health stock for Q4 2022, down 24% quarter-over-quarter.
- 44 funds opened new Accendra Health positions in Q4 2022 and 49 closed out, a net change of -5 holders.
- The largest Accendra Health buyer in Q4 2022 was Deerfield Management, an estimated $23M added.
- The largest Accendra Health seller in Q4 2022 was Alyeska Investment Group, an estimated $28.6M sold.
Based on aggregated 13F filings for Q4 2022.